Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis
Open Access
- 20 September 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 53 (1) , 106-115
- https://doi.org/10.1002/hep.23998
Abstract
Nonalcoholic steatohepatitis (NASH) is a leading cause of cirrhosis. Recently, we showed that NASH-related cirrhosis is associated with Hedgehog (Hh) pathway activation. The gene encoding osteopontin (OPN), a profibrogenic extracellular matrix protein and cytokine, is a direct transcriptional target of the Hh pathway. Thus, we hypothesize that Hh signaling induces OPN to promote liver fibrosis in NASH. Hepatic OPN expression and liver fibrosis were analyzed in wild-type (WT) mice, Patched-deficient (Ptc+/−) (overly active Hh signaling) mice, and OPN-deficient mice before and after feeding methionine and choline–deficient (MCD) diets to induce NASH-related fibrosis. Hepatic OPN was also quantified in human NASH and nondiseased livers. Hh signaling was manipulated in cultured liver cells to assess direct effects on OPN expression, and hepatic stellate cells (HSCs) were cultured in medium with different OPN activities to determine effects on HSC phenotype. When fed MCD diets, Ptc+/− mice expressed more OPN and developed worse liver fibrosis ( P < 0.05) than WT mice, whereas OPN-deficient mice exhibited reduced fibrosis ( P < 0.05). In NASH patients, OPN was significantly up-regulated and correlated with Hh pathway activity and fibrosis stage. During NASH, ductular cells strongly expressed OPN. In cultured HSCs, SAG (an Hh agonist) up-regulated, whereas cyclopamine (an Hh antagonist) repressed OPN expression ( P < 0.005). Cholangiocyte-derived OPN and recombinant OPN promoted fibrogenic responses in HSCs ( P < 0.05); neutralizing OPN with RNA aptamers attenuated this ( P < 0.05). Conclusion: OPN is Hh-regulated and directly promotes profibrogenic responses. OPN induction correlates with Hh pathway activity and fibrosis stage. Therefore, OPN inhibition may be beneficial in NASH (Hepatology 2011)Keywords
This publication has 39 references indexed in Scilit:
- In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver diseaseHepatology, 2006
- Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient miceJournal of Hepatology, 2006
- Osteopontin: role in cell signaling and cancer progressionTrends in Cell Biology, 2006
- Expression of Osteopontin Correlates with Portal Biliary Proliferation and Fibrosis in Biliary AtresiaPediatric Research, 2005
- Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for CarcinogenesisGastroenterology, 2005
- Hepatic stellate cells and fibrosis progression in patients with nonalcoholic fatty liver diseaseClinical Gastroenterology and Hepatology, 2005
- Effects and regulation of osteopontin in rat hepatic stellate cellsBiochemical Pharmacology, 2004
- Osteopontin as a Mediator of NKT Cell Function in T Cell-Mediated Liver DiseasesImmunity, 2004
- Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological LesionsAmerican Journal of Gastroenterology, 1999
- Primary culture of cholangiocytes from normal mouse liverIn Vitro Cellular & Developmental Biology – Animal, 1998